pdk1 inhibitor ar 12 (MedChemExpress)
Structured Review
Pdk1 Inhibitor Ar 12, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdk1+inhibitor/OSU-03012/pm42086185-130-16-19
Average 94 stars, based on 7 article reviews
Images
Related Articles
Control:Article Title: Hypoxia within tumor microenvironment characterizes distinct genomic patterns and aids molecular subtyping for guiding individualized immunotherapy Article Snippet: .. Treatments included administration of a mouse anti-PD-1 monoclonal antibody (mAb) (BioXcell, BE0146, 100 μg per mouse), an IgG isotype control (BioXcell, BE0089, 100 μg per mouse), a Cell Culture:Article Title: PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway. Article Snippet: The phosphatidylinositol‐3‐kinase catalytic subunit α (PIK3CA) gene is mutated in numerous human cancers.. This mutation promotes the proliferation of tumor cells; however, the underlying mechanism is still not clear.. In the present study, it was revealed that the PIK3CA muta‐ tion in colorectal cancer (CRC) HCT116 (MUT) rendered the cells more dependent on glutamine by regulating the glutamic‐pyruvate transaminase 2 (GPT2). Inhibition:Article Title: PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway. Article Snippet: The phosphatidylinositol‐3‐kinase catalytic subunit α (PIK3CA) gene is mutated in numerous human cancers.. This mutation promotes the proliferation of tumor cells; however, the underlying mechanism is still not clear.. In the present study, it was revealed that the PIK3CA muta‐ tion in colorectal cancer (CRC) HCT116 (MUT) rendered the cells more dependent on glutamine by regulating the glutamic‐pyruvate transaminase 2 (GPT2). Staining:Article Title: PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway. Article Snippet: The phosphatidylinositol‐3‐kinase catalytic subunit α (PIK3CA) gene is mutated in numerous human cancers.. This mutation promotes the proliferation of tumor cells; however, the underlying mechanism is still not clear.. In the present study, it was revealed that the PIK3CA muta‐ tion in colorectal cancer (CRC) HCT116 (MUT) rendered the cells more dependent on glutamine by regulating the glutamic‐pyruvate transaminase 2 (GPT2). |


